Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration

被引:32
|
作者
Trissel, LA
Gilbert, DL
Martinez, JF
Baker, MB
Walter, WV
Mirtallo, JM
机构
[1] ABBOTT LABS,HOSP PROD DIV,ABBOTT PK,IL 60064
[2] MCGAW INC,PHARMACEUT DEV,IRVINE,CA
[3] OHIO STATE UNIV,MED CTR,COLUMBUS,OH 43210
关键词
anti-infective agents; antineoplastic agents; anxiolytics; sedatives and hypnotics; cardiac drugs; compounding; dextrose; diluents; formulations; incompatibilities; injections; nutrition; sodium chloride; stability;
D O I
10.1093/ajhp/54.11.1295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The compatibility of 102 drugs with parenteral nutrient(PN) solutions during simulated Y-site administration was studied. Five milliliters of each of four representative PN solutions was combined in duplicate in a 1:1 ratio with 5-mL samples of solutions of 102 drugs in 5% dextrose injection or 0.9% sodium chloride injection. Visual examinations were performed in fluorescent laboratory light and under high-intensity monodirectional light, and turbidity was measured. Particle sizing and counting were performed for selected solutions. All evaluations were performed at intervals up to four hours; storage was at 23 degrees C. Most of the drugs tested were compatible with the PN solutions. However, 20 drugs exhibited various incompatibilities with one or more of the TN solutions. During simulated Y-site administration, four PN solutions were compatible with 82 of 102 drugs for four hours at 23 degrees C. Twenty drugs were incompatible with one or more of the PN solutions.
引用
收藏
页码:1295 / 1300
页数:6
相关论文
共 50 条
  • [1] PHYSICAL COMPATIBILITY OF IBUPROFEN AND SELECTED PARENTERAL DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    Dettlaff, Katarzyna
    Dominiak, Katarzyna
    Klimaszewska, Marta
    Gostynska, Aleksandra
    [J]. ACTA POLONIAE PHARMACEUTICA, 2023, 80 (02): : 255 - 267
  • [2] COMPATIBILITY OF FILGRASTIM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (15): : 1907 - 1913
  • [3] COMPATIBILITY OF AZTREONAM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (10) : 1086 - 1090
  • [4] COMPATIBILITY OF AMIFOSTINE WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (20) : 2208 - 2212
  • [5] Visual compatibility of blinatumomab with selected drugs during simulated Y-site administration
    Du Repaire, Theau
    Vigne, Petula
    Guedon, Amaury
    Fanciullino, Raphaelle
    Gauthier-Villano, Laurence
    Peres, Pierre Bertault
    Pourroy, Bertrand
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (16) : 1217 - 1218
  • [6] PHYSICAL COMPATIBILITY OF MELPHALAN WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (11): : 2359 - 2363
  • [7] Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration
    Trissel, LA
    Martinez, JF
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (09) : 1041 - 1045
  • [8] Visual compatibility of defibrotide with selected drugs during simulated Y-site administration
    Correard, Florian
    Savry, Amandine
    Gauthier-Villano, Laurence
    Pisano, Pascale
    Pourroy, Bertrand
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (15) : 1288 - 1291
  • [9] Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration
    Hall, PD
    Yui, D
    Lyons, S
    Bosso, JA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (02) : 185 - 189
  • [10] Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration
    Chan, Pak
    Bishop, Amanda
    Kuplec, Thomas C.
    Trissel, Lawrence A.
    Gole, Dilip
    Jimidar, Ilias M.
    Vermeersch, Hans
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1545 - 1551